US5919210A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Device and method for detection and treatment of syncope
Assignee: MINN SHARES Inc
•
Filing: 1997-04-10
•
Granted: 1999-07-06
•
Expires: 2017-04-10
Abstract
Abstract The invention disclosed herein relates to an implantable medical device for detection and treatment of syncope comprising an algorithm for determining the presence of syncope based on physiological activity associated with the onset of a syncopal episode, and a means for infusion a drug. Drug infusion therapy may be used along or in combination with pacing. The physiological activities detected and used by the device are selected from the group including changes in heart rate, heart rate variability, QT interval, PR interval, pressure, blood flow, vagal nerve activity, temperature, pH, and AV conduction times, respiration rate, position, motion, and combinations thereof. Drugs which may be used with the invention include pharmaceutical compositions which are capable of both endocardial administration and treatment of syncope, such as compositions comprising beta-blockers.
Inventors
- 👤 Keith G. Lurie
- 👤 David Benditt
- 👤 Stanislao F. Obino
- 👤 Paul J. Buscemi
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-27 22:53
CPC Classifications
A; A61; A61M; A61M5/00; A61M5/14; A61M5/168; A61M5/172; A61M5/1723; A61N; A61N1/00; A61N1/18; A61N1/32; A61N1/36; A61N1/362; A61N1/365; A61N1/36514; A61N1/36571; A61N1/36592
Claims Analysis
Total Claims: 14
Claim 1
Independent Claim
47 words
An implantable device for detection and treatment of syncope comprising: means for sensing physiological activity associated with the onset of syncope; means for determining the onset of syncope; and means for infusing a therapeutically effective amount of a pharmaceutical composition for treating syncope directly into the heart.
Claim 2
Dependent Claim
47 words
An implantable device for detection and treatment of syncope comprising: means for sensing physiological activity associated with the onset of syncope; means for determining the onset of syncope; and means for infusing a therapeutically effective amount of a pharmaceutical composition for treating syncope directly into the heart.
Claim 3
Dependent Claim
45 words
The implantable device of claim 1, wherein the sensed physiological activity associated with syncope is selected from the group consisting of heart rate, heart rate variability, QT interval, PR interval, pressure, blood flow, vagal nerve activity, temperature, pH, and Av conduction times, and combinations thereof.
Claim 4
Dependent Claim
10 words
The implantable device of claim 1, further comprising pacing means.
Claim 5
Independent Claim
57 words
A method for detection and endocardial treatment of syncope in a patient in need of treatment thereof, comprising: sensing physiological activity associated with the onset of syncope; determining the presence of an onset of syncope; and infusing a therapeutically effective amount of a pharmaceutical composition for treating syncope directly into the heart in response to said determination.
Claim 6
Independent Claim
57 words
A method for detection and endocardial treatment of syncope in a patient in need of treatment thereof, comprising: sensing physiological activity associated with the onset of syncope; determining the presence of an onset of syncope; and infusing a therapeutically effective amount of a pharmaceutical composition for treating syncope directly into the heart in response to said determination.
Claim 7
Independent Claim
56 words
A method for treating syncope comprising the steps of: determining the QT/R--R ratio of a patient's heart beat; comparing the determined QT/R--R ratio with a baseline value for the QT/R--R ratio; and infusing a drug into the heart for treatment of syncope, if the determined value of the QT/R--R ratio is less than the baseline value.
Claim 8
Independent Claim
56 words
A method for treating syncope comprising the steps of: determining the QT/R--R ratio of a patient's heart beat; comparing the determined QT/R--R ratio with a baseline value for the QT/R--R ratio; and infusing a drug into the heart for treatment of syncope, if the determined value of the QT/R--R ratio is less than the baseline value.
Claim 9
Dependent Claim
42 words
A method in accordance with claim 5, wherein the baseline value is determined by an average of the QT/R--R ratio for the patient over at least about the previous 1 to 5 minutes prior to the determining of the current QT/R--R ratio.
Claim 10
Independent Claim
80 words
A method for treating syncope, comprising the steps of: making a first comparison of the current QT/R--R ratio value of a patient to a baseline value; making a second comparison of the then current value of the patient's QT/R--R ratio with the baseline value at least about 1 minute after the first comparison; and infusing drugs to the heart if the then current values of the QT/R--R ratios for the first and second comparison are less than the baseline values.
Claim 11
Independent Claim
80 words
A method for treating syncope, comprising the steps of: making a first comparison of the current QT/R--R ratio value of a patient to a baseline value; making a second comparison of the then current value of the patient's QT/R--R ratio with the baseline value at least about 1 minute after the first comparison; and infusing drugs to the heart if the then current values of the QT/R--R ratios for the first and second comparison are less than the baseline values.
Claim 12
Dependent Claim
42 words
A method in accordance with claim 7, wherein the baseline value is determined by an average of the QT/R--R ratio for the patient over at least about the previous 1 to 5 minutes prior to the determining of the current QT/R--R ratio.
Claim 13
Dependent Claim
80 words
The method in accordance with claim 7, comprising the further step of: making a third comparison, about 3 to 60 seconds after the second comparison, between the current value of the QT/R--R ratio and the then current QT/R--R ratio measured during the second comparison; and pacing the heart if the current value of the QT/R--R ratio at the time of the third comparison is less than the current value of the QT/R--R ratio at the time of the second comparison.
Claim 14
Dependent Claim
81 words
The method in accordance with claim 7, comprising the further step of: making a third comparison, about 30 to 60 seconds after the second comparison, between the current value of the QT/R--R ratio and the then current QT/R--R ration measured during the second comparison; and pacing the heart if the current value of the QT/R--R ratio at the time of the third comparison is less than the expected value based upon trend analysis comparing the first and second QT/R--R ratio measurements.
References Cited (Backward Citations)
US3358690A
Cited
US3593718A
Cited
US3857399A
Cited
US4146029A
Cited
US4009721A
Cited
US4252124A
Cited
US4312355A
Cited
US4202339A
Cited
US4193393A
Cited
US4228803A
Cited
US4313442A
Cited
US4428378A
Cited
US4566456A
Cited
US4730619A
Cited
US4791931A
Cited
US5113859A
Cited
US4960129A
Cited
US5040533A
Cited
US5065759A
Cited
US5233984A
Cited
US5213098A
Cited
US5342404A
Cited
US5464434A
Cited
US5330505A
Cited
US5501701A
Cited
US5441525A
Cited
US5540728A
Cited
US5676686A
Cited
US5527344A
Cited
US5560368A
Cited
US5514163A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2002-07-05 | 2003-01-04 | 2003-07-06 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2006-07-05 | 2007-01-04 | 2007-07-06 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2010-07-05 | 2011-01-04 | 2011-07-06 | $7700.00 | Window Closed / Lapsed |